Nichols William Garrett 4
4 · Candel Therapeutics, Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Nichols William Garrett
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-28$1.29/sh+937$1,209→ 53,430 total - Sale
Common Stock
2025-07-28$6.98/sh−937$6,540→ 52,493 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-28−937→ 29,377 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (937 underlying)
Footnotes (2)
- [F1]This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.
- [F2]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.